BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Borel B, Provencher S, Saey D, Maltais F. Responsiveness of Various Exercise-Testing Protocols to Therapeutic Interventions in COPD. Pulm Med 2013;2013:410748. [PMID: 23431439 DOI: 10.1155/2013/410748] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 3.8] [Reference Citation Analysis]
Number Citing Articles
1 Valeiro B, Hernández C, Barberán-garcia A, Rodríguez DA, Aibar J, Llop L, Vilaró J. Viabilidad de la evaluación domiciliaria del estado funcional de pacientes con enfermedad pulmonar obstructiva crónica en fase de recuperación de una exacerbación. Archivos de Bronconeumología 2016;52:256-61. [DOI: 10.1016/j.arbres.2015.10.010] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
2 Prieur G, Beaumont M, Delorme M, Combret Y, Medrinal C, Hilfiker R, Bonnevie T, Gravier FE, Smondack P, Lamia B, Reychler G. Short-term effects of menthol on walking dyspnoea in patients with COPD: a randomised, single blinded, cross-over study. ERJ Open Res 2021;7:00450-2021. [PMID: 34708112 DOI: 10.1183/23120541.00450-2021] [Reference Citation Analysis]
3 Silva ALGD, Garmatz E, Goulart CDL, Carvalho LL, Cardoso DM, Paiva DN. Handgrip and functional capacity in Chronic Obstructive Pulmonary Disease patients. Fisioter mov 2017;30:501-7. [DOI: 10.1590/1980-5918.030.003.ao08] [Cited by in Crossref: 5] [Article Influence: 1.0] [Reference Citation Analysis]
4 Valipour A, Tamm M, Kociánová J, Bayer V, Sanzharovskaya M, Medvedchikov A, Haaksma-Herczegh M, Mucsi J, Fridlender Z, Toma C, Belevskiy A, Matula B, Šorli J. Improvement In Self-Reported Physical Functioning With Tiotropium/Olodaterol In Central And Eastern European COPD Patients. Int J Chron Obstruct Pulmon Dis 2019;14:2343-54. [PMID: 31632003 DOI: 10.2147/COPD.S204388] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
5 Borel B, Pepin V, Mahler DA, Nadreau É, Maltais F. Prospective validation of the endurance shuttle walking test in the context of bronchodilation in COPD. Eur Respir J 2014;44:1166-76. [PMID: 25186261 DOI: 10.1183/09031936.00024314] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
6 Boutou AK, Zafeiridis A, Pitsiou G, Dipla K, Kioumis I, Stanopoulos I. Cardiopulmonary exercise testing in chronic obstructive pulmonary disease: An update on its clinical value and applications. Clin Physiol Funct Imaging 2020;40:197-206. [PMID: 32176429 DOI: 10.1111/cpf.12627] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
7 Miranda NADF, Goulart CDL, Silva ABE, Cardoso DM, Paiva DN, Trimer R, da Silva ALG. Does peripheral arterial occlusive disease influence muscle strength and exercise capacity in COPD patients? J Vasc Bras 2017;16:285-92. [PMID: 29930662 DOI: 10.1590/1677-5449.004417] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
8 Maltais F, O'Donnell D, Gáldiz Iturri JB, Kirsten AM, Singh D, Hamilton A, Tetzlaff K, Zhao Y, Casaburi R. Effect of 12 weeks of once-daily tiotropium/olodaterol on exercise endurance during constant work-rate cycling and endurance shuttle walking in chronic obstructive pulmonary disease. Ther Adv Respir Dis 2018;12:1753465818755091. [PMID: 29439648 DOI: 10.1177/1753465818755091] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 6.0] [Reference Citation Analysis]
9 Possner M, Chaudhry A, Dillman JR, Urbina EM, Gao Z, McCoy C, Faust M, Rossiter HB, Powell AW, Mays W, Veldtman G. Dynamic exercise changes in venous pressure and liver stiffness in Fontan patients: effects of Treprostinil. Cardiol Young 2021;:1-7. [PMID: 33504408 DOI: 10.1017/S1047951121000159] [Reference Citation Analysis]
10 Adolfo JR, Dhein W, Sbruzzi G. Intensity of physical exercise and its effect on functional capacity in COPD: systematic review and meta-analysis. J Bras Pneumol 2019;45:e20180011. [PMID: 31576905 DOI: 10.1590/1806-3713/e20180011] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
11 Reychler G, Poncin W, Montigny S, Luts A, Caty G, Pieters T. Efficacy of yoga, tai chi and qi gong on the main symptoms of chronic obstructive pulmonary disease: A systematic review. Respir Med Res 2019;75:13-25. [PMID: 31235453 DOI: 10.1016/j.resmer.2019.04.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
12 Casey D, Murphy K, Devane D, Cooney A, McCarthy B, Mee L, Newell J, O'Shea E, Scarrott C, Gillespie P, Kirwan C, Murphy AW. The effectiveness of a structured education pulmonary rehabilitation programme for improving the health status of people with moderate and severe chronic obstructive pulmonary disease in primary care: the PRINCE cluster randomised trial. Thorax 2013;68:922-8. [PMID: 23736156 DOI: 10.1136/thoraxjnl-2012-203103] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 2.1] [Reference Citation Analysis]
13 Lévesque J, Antoniadis A, Li PZ, Herengt F, Brosson C, Grosbois JM, Bernady A, Bender A, Favre M, Guerder A, Surpas P, Similowski T, Aguilaniu B. Minimal clinically important difference of 3-minute chair rise test and the DIRECT questionnaire after pulmonary rehabilitation in COPD patients. Int J Chron Obstruct Pulmon Dis 2019;14:261-9. [PMID: 30774324 DOI: 10.2147/COPD.S187567] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
14 Ejiofor SI, Bayliss S, Gassamma A, Turner AM. Ambulatory Oxygen for Exercise-Induced Desaturation and Dyspnea in Chronic Obstructive Pulmonary Disease (COPD): Systematic Review and Meta-Analysis. Chronic Obstr Pulm Dis 2016;3:419-34. [PMID: 28848863 DOI: 10.15326/jcopdf.3.1.2015.0146] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
15 O'Donnell DE, Gebke KB. Activity restriction in mild COPD: a challenging clinical problem. Int J Chron Obstruct Pulmon Dis 2014;9:577-88. [PMID: 24940054 DOI: 10.2147/COPD.S62766] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.3] [Reference Citation Analysis]
16 Wootton SL, Ng C, McKeough ZJ, Jenkins S, Hill K, Alison JA. Estimating endurance shuttle walk test speed using the six-minute walk test in people with chronic obstructive pulmonary disease. Chron Respir Dis 2014;11:89-94. [PMID: 24659209 DOI: 10.1177/1479972314527470] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
17 Lange P, Halpin DM, O'Donnell DE, MacNee W. Diagnosis, assessment, and phenotyping of COPD: beyond FEV₁. Int J Chron Obstruct Pulmon Dis 2016;11 Spec Iss:3-12. [PMID: 26937185 DOI: 10.2147/COPD.S85976] [Cited by in Crossref: 10] [Cited by in F6Publishing: 32] [Article Influence: 1.7] [Reference Citation Analysis]
18 O'Donnell DE, Gebke KB. Examining the role of activity, exercise, and pharmacology in mild COPD. Postgrad Med 2014;126:135-45. [PMID: 25295658 DOI: 10.3810/pgm.2014.09.2808] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
19 Hill K, Ng C, Wootton SL, Mckeough ZJ, Eastwood PR, Hillman DR, Jenkins C, Spencer L, Jenkins SC, Cecins NM, Alison JA. The minimal detectable difference for endurance shuttle walk test performance in people with COPD on completion of a program of high-intensity ground-based walking. Respiratory Medicine 2019;146:18-22. [DOI: 10.1016/j.rmed.2018.11.013] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
20 Bughin F, Desplan M, Mestejanot C, Picot MC, Roubille F, Jaffuel D, Mercier J, Jaussent I, Dauvilliers Y. Effects of an individualized exercise training program on severity markers of obstructive sleep apnea syndrome: a randomised controlled trial. Sleep Med 2020;70:33-42. [PMID: 32193052 DOI: 10.1016/j.sleep.2020.02.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
21 Usmani OS, Dhand R, Lavorini F, Price D. Why We Should Target Small Airways Disease in Our Management of Chronic Obstructive Pulmonary Disease. Mayo Clin Proc 2021;96:2448-63. [PMID: 34183115 DOI: 10.1016/j.mayocp.2021.03.016] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
22 Hill K, Dolmage TE. Take a Deep Breath: More Support for Noninvasive Ventilation During Exercise in People With COPD. Chest 2021;160:1991-2. [PMID: 34872659 DOI: 10.1016/j.chest.2021.09.001] [Reference Citation Analysis]
23 Maltais F, Kirsten AM, Hamilton A, De Sousa D, Voß F, Decramer M. Evaluation of the effects of olodaterol on exercise endurance in patients with chronic obstructive pulmonary disease: results from two 6-week crossover studies. Respir Res 2016;17:77. [PMID: 27383762 DOI: 10.1186/s12931-016-0389-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
24 Sandberg C, Hedström M, Wadell K, Dellborg M, Ahnfelt A, Zetterström A, Öhrn A, Johansson B. Home-based interval training increases endurance capacity in adults with complex congenital heart disease. Congenital Heart Disease 2018;13:254-62. [DOI: 10.1111/chd.12562] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
25 O'Donnell DE, Elbehairy AF, Faisal A, Webb KA, Neder JA, Mahler DA. Exertional dyspnoea in COPD: the clinical utility of cardiopulmonary exercise testing. Eur Respir Rev 2016;25:333-47. [PMID: 27581832 DOI: 10.1183/16000617.0054-2016] [Cited by in Crossref: 45] [Cited by in F6Publishing: 40] [Article Influence: 9.0] [Reference Citation Analysis]
26 Andrianopoulos V, Wagers SS, Groenen MT, Vanfleteren LE, Franssen FM, Smeenk FW, Vogiatzis I, Wouters EF, Spruit MA; CIRO+ Rehabilitation Network. Characteristics and determinants of endurance cycle ergometry and six-minute walk distance in patients with COPD. BMC Pulm Med 2014;14:97. [PMID: 24885117 DOI: 10.1186/1471-2466-14-97] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
27 Polkey MI, Praestgaard J, Berwick A, Franssen FME, Singh D, Steiner MC, Casaburi R, Tillmann HC, Lach-Trifilieff E, Roubenoff R, Rooks DS. Activin Type II Receptor Blockade for Treatment of Muscle Depletion in Chronic Obstructive Pulmonary Disease. A Randomized Trial. Am J Respir Crit Care Med 2019;199:313-20. [PMID: 30095981 DOI: 10.1164/rccm.201802-0286OC] [Cited by in Crossref: 38] [Cited by in F6Publishing: 17] [Article Influence: 12.7] [Reference Citation Analysis]
28 Borel B, Wilkinson-Maitland CA, Hamilton A, Bourbeau J, Perrault H, Jensen D, Maltais F. Three-minute constant rate step test for detecting exertional dyspnea relief after bronchodilation in COPD. Int J Chron Obstruct Pulmon Dis 2016;11:2991-3000. [PMID: 27942208 DOI: 10.2147/COPD.S113113] [Cited by in Crossref: 13] [Cited by in F6Publishing: 4] [Article Influence: 2.2] [Reference Citation Analysis]
29 Bernard S, Ribeiro F, Maltais F, Saey D. Prescribing exercise training in pulmonary rehabilitation: a clinical experience. Rev Port Pneumol 2014;20:92-100. [PMID: 24480488 DOI: 10.1016/j.rppneu.2013.10.005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
30 O'Donnell DE, Casaburi R, Frith P, Kirsten A, De Sousa D, Hamilton A, Xue W, Maltais F. Effects of combined tiotropium/olodaterol on inspiratory capacity and exercise endurance in COPD. Eur Respir J 2017;49:1601348. [PMID: 28424359 DOI: 10.1183/13993003.01348-2016] [Cited by in Crossref: 38] [Cited by in F6Publishing: 47] [Article Influence: 7.6] [Reference Citation Analysis]
31 Maltais F, O'Donnell DE, Hamilton A, Zhao Y, Casaburi R. Comparative measurement properties of constant work rate cycling and the endurance shuttle walking test in COPD: the TORRACTO® clinical trial. Ther Adv Respir Dis 2020;14:1753466620926858. [PMID: 32482147 DOI: 10.1177/1753466620926858] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
32 Kakavas S, Kotsiou OS, Perlikos F, Mermiri M, Mavrovounis G, Gourgoulianis K, Pantazopoulos I. Pulmonary function testing in COPD: looking beyond the curtain of FEV1. NPJ Prim Care Respir Med 2021;31:23. [PMID: 33963190 DOI: 10.1038/s41533-021-00236-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
33 Skogvall S, Erjefält JS, Olin AI, Ankerst J, Bjermer L. Oral iodinated activated charcoal improves lung function in patients with COPD. Respir Med 2014;108:905-9. [PMID: 24742364 DOI: 10.1016/j.rmed.2014.03.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
34 Reuveny R, DiMenna FJ, Gunaratnam C, Arad AD, McElvaney GN, Susta D, Peled M, Moyna NM. High-intensity interval training accelerates oxygen uptake kinetics and improves exercise tolerance for individuals with cystic fibrosis. BMC Sports Sci Med Rehabil 2020;12:9. [PMID: 32308986 DOI: 10.1186/s13102-020-0159-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
35 Reychler G, Boucard E, Peran L, Pichon R, Le Ber-moy C, Ouksel H, Liistro G, Chambellan A, Beaumont M. One minute sit-to-stand test is an alternative to 6MWT to measure functional exercise performance in COPD patients. Clin Respir J 2018;12:1247-56. [DOI: 10.1111/crj.12658] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 3.8] [Reference Citation Analysis]
36 Sebio Garcia R, Yáñez Brage MI, Giménez Moolhuyzen E, Granger CL, Denehy L. Functional and postoperative outcomes after preoperative exercise training in patients with lung cancer: a systematic review and meta-analysis. Interact Cardiovasc Thorac Surg 2016;23:486-97. [PMID: 27226400 DOI: 10.1093/icvts/ivw152] [Cited by in Crossref: 90] [Cited by in F6Publishing: 81] [Article Influence: 15.0] [Reference Citation Analysis]
37 Derom E, Brusselle GG, Joos GF. The once-daily fixed-dose combination of olodaterol and tiotropium in the management of COPD: current evidence and future prospects. Ther Adv Respir Dis 2019;13:1753466619843426. [PMID: 31002020 DOI: 10.1177/1753466619843426] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
38 Sawyer A, Cavalheri V, Jenkins S, Wood J, Cecins N, Singh B, Hill K. Effects of high intensity interval training on exercise capacity in people with cystic fibrosis: study protocol for a randomised controlled trial. BMC Sports Sci Med Rehabil 2018;10:19. [PMID: 30450213 DOI: 10.1186/s13102-018-0108-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
39 Prieur G, Combret Y, Medrinal C. The use of menthol for breathlessness: a hot topic full of fresh ideas. ERJ Open Res 2022;8:00161-2022. [PMID: 35539435 DOI: 10.1183/23120541.00161-2022] [Reference Citation Analysis]